Pharmacogenomics and regulatory decision making: an international perspective

被引：0
|
作者：
D L Mendrick
C Brazell
E A Mansfield
R Pietrusko
I Barilero
J Hackett
S Stürzebecher
D Jacobson-Kram
机构：
[1] Toxicogenomics,
[2] Gene Logic Inc.,undefined
[3] Genetics Research,undefined
[4] GlaxoSmithKline,undefined
[5] Regulatory Affairs,undefined
[6] Affymetrix Inc.,undefined
[7] Worldwide Regulatory Affairs,undefined
[8] Millennium Pharmaceuticals,undefined
[9] Inc.,undefined
[10] Global Regulatory Policy and Intelligence,undefined
[11] Johnson & Johnson Pharmaceutical Research and Development,undefined
[12] Office of In Vitro Diagnostic Device Evaluation and Safety,undefined
[13] CDRH,undefined
[14] Corporate Preclinical Development,undefined
[15] Office of New Drugs,undefined
[16] CDER,undefined
来源：
The Pharmacogenomics Journal | 2006年 / 6卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：154 / 157
页数：3
相关论文
共 50 条
  • [21] The Regulatory Imperative: International Perspective
    Bertram, Tim
    Hellman, Kiki B.
    Bayon, Yves
    Ellison, Simon
    Wilburn, Sarah
    TISSUE ENGINEERING PART B-REVIEWS, 2013, 19 (03) : 191 - 193
  • [22] Policy and practice developments in the implementation of shared decision-making: an international perspective
    Haerter, Martin
    van der Weijden, Trudy
    Elwyn, Glyn
    ZEITSCHRIFT FUR EVIDENZ FORTBILDUNG UND QUALITAET IM GESUNDHEITSWESEN, 2011, 105 (04): : 229 - 233
  • [23] REFORMING REGULATORY DECISION-MAKING - THE REGULATORY BUDGET
    THOMPSON, F
    JONES, LR
    SLOAN MANAGEMENT REVIEW, 1981, 22 (02): : 53 - 61
  • [24] The Influence Of Decision-Maker Characteristics On The International Strategic Decision-Making Process: An SME Perspective
    Musso, Fabio
    Francioni, Barbara
    8TH INTERNATIONAL STRATEGIC MANAGEMENT CONFERENCE, 2012, 58 : 279 - 288
  • [25] An Evidence-Based Tool for Regulatory Decision Making: The Regulatory Decision Pathway
    Russell, Kathleen A.
    Radtke, Beth K.
    JOURNAL OF NURSING REGULATION, 2014, 5 (02) : 5 - 9
  • [26] The Role of Statistics in Regulatory Decision Making
    LaVange, Lisa M.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2014, 48 (01) : 10 - 19
  • [27] ENCePP Supporting Regulatory Decision Making
    Blackburn, Stella
    Blake, Kevin
    Kurz, Xavier
    Slattery, Jim
    Fitt, Henry
    Arlett, Peter
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 86 - 87
  • [28] The Role of Statistics in Regulatory Decision Making
    Lisa M. LaVange
    Therapeutic Innovation & Regulatory Science, 2014, 48 : 10 - 19
  • [29] INTERNATIONAL DECISION-MAKING AND DECISION-MAKING PROBLEMS IN INTERNATIONAL-BUSINESS ACTIVITY
    MACHARZINA, K
    ENGELHARD, J
    BETRIEBSWIRTSCHAFTLICHE FORSCHUNG UND PRAXIS, 1984, 36 (04): : 297 - 322
  • [30] Pharmacometrics for Regulatory Decision MakingStatus and Perspective
    Efthymios Manolis
    Ralf Herold
    Clinical Pharmacokinetics, 2011, 50 : 625 - 626
12345